Immunomodulatory IL-18 binding protein is produced by prostate cancer cells and its levels in urine and serum correlate with tumor status.

Abstract

No abstract available.

Authors
  • Ewing CM
  • Fujita K
  • Isaacs WB
  • Pavlovich CP
PubMed ID
20878981
Appears In